NURIX THERAPEUTICS INC

Ticker: NRIX CUSIP: 67080M103 Class: Common Stock

Connor, Clark & Lunn Investment Management Ltd.'s Holding History (CIK: 0001596800)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025

Shares 61,515 Value ($000) $568 Avg Close $10.38 Range $8.20 - $14.56

Q2 2024

Shares 62,298 Value ($000) $1,300 Avg Close $15.57 Range $11.90 - $22.44

Q1 2024

Shares 237,104 Value ($000) $3,485 Avg Close $10.76 Range $7.65 - $16.11

Q4 2023

Shares 185,070 Value ($000) $1,910 Avg Close $6.85 Range $4.22 - $10.78

Q3 2023

Shares 183,923 Value ($000) $1,446 Avg Close $9.13 Range $7.78 - $11.58

Q2 2023

Shares 130,494 Value ($000) $1,304 Avg Close $10.20 Range $8.46 - $13.99

Q1 2023

Shares 13,048 Value ($000) $116 Avg Close $10.42 Range $8.34 - $13.40

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2025	61,515	$568	$10.38	$8.20 - $14.56
Q2 2024	62,298	$1,300	$15.57	$11.90 - $22.44
Q1 2024	237,104	$3,485	$10.76	$7.65 - $16.11
Q4 2023	185,070	$1,910	$6.85	$4.22 - $10.78
Q3 2023	183,923	$1,446	$9.13	$7.78 - $11.58
Q2 2023	130,494	$1,304	$10.20	$8.46 - $13.99
Q1 2023	13,048	$116	$10.42	$8.34 - $13.40